| pubmed-article:7121739 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7121739 | lifeskim:mentions | umls-concept:C0007450 | lld:lifeskim |
| pubmed-article:7121739 | lifeskim:mentions | umls-concept:C0504074 | lld:lifeskim |
| pubmed-article:7121739 | lifeskim:mentions | umls-concept:C0034441 | lld:lifeskim |
| pubmed-article:7121739 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:7121739 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:7121739 | lifeskim:mentions | umls-concept:C0439148 | lld:lifeskim |
| pubmed-article:7121739 | lifeskim:mentions | umls-concept:C1879743 | lld:lifeskim |
| pubmed-article:7121739 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:7121739 | pubmed:dateCreated | 1982-12-2 | lld:pubmed |
| pubmed-article:7121739 | pubmed:abstractText | Quipazine produced a dose-dependent decrease in the discharge rate of serotonin-containing neurons in the dorsal raphe nucleus of freely-moving cats. This ranged from a 10% decrease at 0.5 mg/kg, (i.p.), to a virtually complete depression of activity at 5.0 mg/kg. The effects of quipazine on raphe units occurred with a short latency (5--10 min) and its duration of action was dose-dependent and lasted from 1 to 6 hr. The degree of depression of raphe unit activity was directly related to the frequency of occurrence of a number of behaviors such as limb flicking and abortive grooming. There was a close temporal correlation between the depression of raphe unit activity and the occurrence of these behaviors. These data reveal that quipazine produces behavioral and raphe unit changes similar to those observed after administration of hallucinogens with an indole nucleus. | lld:pubmed |
| pubmed-article:7121739 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7121739 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7121739 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7121739 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7121739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7121739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7121739 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7121739 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7121739 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:7121739 | pubmed:issn | 0028-3908 | lld:pubmed |
| pubmed-article:7121739 | pubmed:author | pubmed-author:TrulsonM EME | lld:pubmed |
| pubmed-article:7121739 | pubmed:author | pubmed-author:HowellG AGA | lld:pubmed |
| pubmed-article:7121739 | pubmed:author | pubmed-author:CrispTT | lld:pubmed |
| pubmed-article:7121739 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7121739 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:7121739 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7121739 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7121739 | pubmed:pagination | 681-6 | lld:pubmed |
| pubmed-article:7121739 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:meshHeading | pubmed-meshheading:7121739-... | lld:pubmed |
| pubmed-article:7121739 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:7121739 | pubmed:articleTitle | Raphe unit activity in freely moving cats: effects of quipazine. | lld:pubmed |
| pubmed-article:7121739 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7121739 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
